Nesiritide (Natrecor) is the recombinant form of the 32 amino acid human B-type
natriuretic peptide, which is normally produced by the ventricular myocardium.
Easy to read patient leaflet for nesiritide. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Jul 7, 2011 ... Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised ...
Jun 13, 2016 ... Acute decompensated heart failure (HF) is a common and potentially fatal cause
of acute respiratory distress. The clinical syndrome is ...
Objectives This study was designed to determine whether nesiritide,
administered for acute decompensated congestive heart failure (CHF), affects
Feb 15, 2006 ... Nesiritide improves short-term hemodynamics in hospitalized patients with acute
decompensated heart failure who have not benefited from ...
Moreover, some investigators reported that nesiritide therapy was safer than the
use of positive inotropic drugs in the setting of ADHF. These results increased ...
Oct 21, 2007 ... Nesiritide is a medication used to treat acutely decompensated congestive heart
failure with dyspnea at rest or with minimal exertion (such as ...
Number: 0709. Policy. Aetna considers nesiritide (Natrecor) medically necessary
for the acute management of members with acutely decompensated congestive ...
Mar 27, 2002 ... Research from JAMA — Intravenous Nesiritide vs Nitroglycerin for Treatment of
Decompensated Congestive Heart Failure — A Randomized ...